[Changes in the effect of drugs due to reciprocal interference with their protein binding and catabolism].
D000328:Adult; D000818:Animals; D000925:Anticoagulants / Q000494:pharmacology; D001463:Barbiturates / Q000378:metabolism; D003577:Cytochrome P-450 Enzyme System; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004336:Drug Antagonism; D004347:Drug Interactions; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D004721:Endoplasmic Reticulum / Q000378:metabolism; D004790:Enzyme Induction / Q000187:drug effects*; D005260:Female; D005942:Gluconates / Q000378:metabolism; D006801:Humans; D007099:Imipramine / Q000378:metabolism; D007668:Kidney / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008657:Metabolic Clearance Rate; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D010672:Phenytoin / Q000378:metabolism; D011485:Protein Binding / Q000187:drug effects*; D011817:Rabbits; D051381:Rats; D013997:Time Factors
D000925:Anticoagulants; D001463:Barbiturates; D005942:Gluconates; D004364:Pharmaceutical Preparations; D010672:Phenytoin; D003577:Cytochrome P-450 Enzyme System; D007099:Imipramine
Wirkungsänderungen von Arzneimitteln durch gegenseitige Störung ihrer Eiweissbindung und ihres Abbaus.